Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 127

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 127
---
 Nasdaq, which generally controls the ability of brokers to vote or not vote shares held in street name on certain matters, and thus will not result in broker non-votes.

THE TELO BOARD RECOMMENDS THAT TELO’S STOCKHOLDERS VOTE “FOR” PROPOSAL NO. 7 TO POSTPONE OR ADJOURN THE TELO ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF PROPOSAL NO. 1, 2, 3, 4, 5 AND 6.

| 74 |

<div align='center'>PRINCIPAL STOCKHOLDERS OF TELOMIR PHARMACEUTICALS, INC.</div>

The following table sets forth, as of the date of this proxy statement, the ownership of our securities by: (i) each of our directors, (ii) all persons who, to our knowledge, are the beneficial owners of more than 5% of the outstanding shares of common stock, (iii) each of the executive officers, and (iv) all of our directors and executive officers, as a group. Each person named in this table has sole investment power and sole voting power with respect to the shares of common stock set forth opposite such person’s name, except as otherwise indicated.

The following table is based upon information supplied by officers, directors and principal stockholders and Schedules 13G filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, TELO believes that each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 34,380,971 shares outstanding on November 17, 2025, adjusted as required by rules promulgated by the SEC.

| Name and Address of Beneficial Owner                      |     | Amount and    
 Nature        
 of Beneficial 
 Ownership     |            |     | Percentage of 
 Class         |       |   |
| Directors and Executive Officers (1)                      |     |               |            |     |               |       |   |
| Erez Aminov (2)                                           |     |               |  6,411,200 |     |               | 18.64 | % |
| Alan Weichselbaum                                         |     |               |          - |     |               |     * |